NCT00653549View on ClinicalTrials.gov

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

May 31, 2001

Study Completion Date

May 31, 2001

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

Torsemide

Tablets, 20 mg, single-dose

DRUG

Demadex

tablets, 20 mg, single-dose

Sponsors

Collaborators (1)

Anapharm
All Listed Sponsors
collaborator

Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00653549 - Bioavailability Study of Torsemide Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter